Chair: Hanna Taipaleenmäki
Novel targets of treatment for myeloma-bone interaction (#91)
8:30 AM
Tumour cell dormancy in the skeleton (#92)
9:00 AM
Muscle function matters: role of the tumor-bone microenvironment in regulation of muscle function in cancer (#93)
9:30 AM